Aims: To investigate the impacts of cytomegalovirus (CMV) viral load, TORCH (toxoplasmosis, others, rubella, CMV and herpes) coinfections, CMV glycoprotein B (gB) genotypes and maternal genetic polymorphisms on pregnancy outcomes among CMV-infected women. Methods: A total of 731 CMV-infected pregnant women (634 and 97 with normal and adverse pregnancy outcomes, respectively) were recruited. CMV load quantification and screening of TORCH coinfections were performed by using real-time polymerase chain reaction (PCR) and immunodetection techniques, respectively. Genotyping of CMV gB and maternal NFKB1 -94 ins/del, NFKBIA -826C/T and -881A/G polymorphisms was performed by using PCR-restriction fragment length polymorphism. Results: We found that the mean CMV viral load in women with adverse pregnancy outcomes was significantly higher than that in women with normal outcomes at all pregnancy stages (p < 0.01). We also found that TORCH coinfections resulted in a 1.65-fold (95% CI = 1.00-2.73) increase in the risk of adverse pregnancy outcomes (p = 0.05). Additionally, we noticed no significant difference in the distribution of CMV gB genotypes between women with normal and adverse pregnancy outcomes (p = 0.42). We also observed that the ins/ins variant genotype of the NFKB1 polymorphism could reduce the risk of adverse pregnancy outcomes (OR = 0.38, 95% CI = 0.15-0.98; p = 0.04). Conclusion: CMV viral load, TORCH coinfections and maternal NFKB1 polymorphism could influence pregnancy outcomes among CMV-infected women.

Keywords:
Cytomegalovirus, Glycoprotein B, NFKB1, NFKBIA, Polymorphism, Pregnancy, TORCH, Viral load
1.
Nigro G, Adler SP: Cytomegalovirus infections during pregnancy. Curr Opin Obstet Gynecol 2011;23:123-128.
2.
Adler SP: Screening for cytomegalovirus during pregnancy. Infect Dis Obstet Gynecol 2011;2011:1-9.
3.
Wang C, Zhang X, Bialek S, Cannon MJ: Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis 2011;52:e11-e13.
4.
Nijman J, de Vries LS, Koopman-Esseboom C, Uiterwaal CS, van Loon AM, Verboon-Maciolek MA: Postnatally acquired cytomegalovirus infection in preterm infants: a prospective study on risk factors and cranial ultrasound findings. Arch Dis Child Fetal Neonatal Ed 2012;97:F259-F263.
5.
Iwasenko JM, Howard J, Arbuckle S, Graf N, Hall B, Craig ME, Rawlinson WD: Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy. J Infect Dis 2011;203:1526-1533.
6.
Guo EP, Zhang Z, Li JD, Wang SJ, Song MH: Study on the relationship between TORCH infection and abnormal pregnancy in pregnant women. Modern Prev Med 2008;35:3823-3824.
7.
Alsamarai AM, Aljumaili ZKM: Seroepidemiology of toxoplasma, rubella, cytomegalovirus and herpes simplex virus-2 in women with bad obstetric history. Part I: toxoplasma and rubella infections. Our Dermatol Online 2013;4:522-535.
8.
Renzette N, Bhattacharjee B, Jensen JD, Gibson L, Kowalik TF: Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants. PLoS Pathog 2011;7:e1001344.
9.
Eickhoff JE, Cotten M: NF-kappaB activation can mediate inhibition of human cytomegalovirus replication. J Gen Virol 2005;86:285-295.
10.
Varani S, Landini MP: Cytomegalovirus-induced immunopathology and its clinical consequences. Herpesviridae 2011;2:6.
11.
Gandhoke I, Hussain SA, Pasha ST, Chauhan LS, Khare S: Glycoprotein B genotyping in congenital/perinatal cytomegalovirus infection in symptomatic infants. Indian Pediatr 2013;50:663-667.
12.
Tan SC, Suzairi MS, Aizat AA, Aminudin MM, Nurfatimah MS, Bhavaraju VM, Biswal BM, Ankathil R: Gender-specific association of NFKBIA promoter polymorphisms with the risk of sporadic colorectal cancer. Med Oncol 2013;30:693.
13.
Mohd Suzairi MS, Tan SC, Ahmad Aizat AA, Mohd Aminudin M, Siti Nurfatimah MS, Andee ZD, Ankathil R: The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer. Cancer Epidemiol 2013;37:634-638.
14.
Lazzarotto T, Varani S, Guerra B, Nicolosi A, Lanari M, Landini MP: Prenatal indicators of congenital cytomegalovirus infection. J Pediatr 2000;137:90-95.
15.
Lazzarotto T, Gabrielli L, Foschini MP, Lanari M, Guerra B, Eusebi V, Landini MP: Congenital cytomegalovirus infection in twin pregnancies: viral load in the amniotic fluid and pregnancy outcome. Pediatrics 2003;112:e153-e157.
16.
Gouarin S, Gault E, Vabret A, Cointe D, Rozenberg F, Grangeot-Keros L, Barjot P, Garbarg-Chenon A, Lebon P, Freymuth F: Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection. J Clin Microbiol 2002;40:1767-1772.
17.
Schleiss MR: Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis. Infect Disord Drug Targets 2011;11:449-465.
18.
Biswas SC, Dey RP: TORCH infection; in Arora M, Sharma A (eds): A Practical Guide to First Trimester of Pregnancy. New Delhi, Jaypee Brothers Medical Publishers, 2014, pp 138-143.
19.
Padmavathy M, Gowri M, Malini J, Umapathy BL, Navaneeth BV, Bhatia M, Harle S: Seroprevalence of TORCH infections and adverse reproductive outcome in current pregnancy with bad obstetric history. J Clin Biomed Sci 2013;3:62-71.
20.
Alsamarai AM, Hassan HMM, Alsalihi FG, Alobaidi AH, Aljumaili ZKM: Toxoplasma gondii, rubella and cytomegalovirus co-infections as risk factors for abnormal pregnancy outcomes. Middle East J Fam Med 2014;12:16-23.
21.
Wu X, Wang Y, Xu Y, Wu D, Sun A, Zhu Z, Han Y, Qiu H, Tang X, Fu Z, He G, Li C, Ma X, Liu Y: Cytomegalovirus glycoprotein B genotype in hematopoietic stem cell transplant patients from China. Biol Blood Marrow Transplant 2010;16:647-652.
22.
Manuel O, Asberg A, Pang X, Rollag H, Emery VC, Preiksaitis JK, Kumar D, Pescovitz MD, Bignamini AA, Hartmann A, Jardine AG, Humar A: Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis 2009;49:1160-1166.
23.
Humar A, Kumar D, Gilbert C, Boivin G: Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease. J Infect Dis 2003;188:581-584.
24.
Wang X, Zuckerman B, Pearson C, Kaufman G, Chen C, Wang G, Niu T, Wise PH, Bauchner H, Xu X: Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 2002;287:195-202.
25.
Tsai HJ, Liu X, Mestan K, Yu Y, Zhang S, Fang Y, Pearson C, Ortiz K, Zuckerman B, Bauchner H, Cerda S, Stubblefield PG, Xu X, Wang X: Maternal cigarette smoking, metabolic gene polymorphisms, and preterm delivery: new insights on GxE interactions and pathogenic pathways. Hum Genet 2008;123:359-369.
26.
Salihu HM, Sharma PP, Getahun D, Hedayatzadeh M, Peters S, Kirby RS, Alio AP, Gaafer-Ahmed H: Prenatal tobacco use and risk of stillbirth: a case-control and bidirectional case-crossover study. Nicotine Tob Res 2008;10:159-166.
27.
Huang ZG, Griffioen KJ, Wang X, Dergacheva O, Kamendi H, Gorini C, Bouairi E, Mendelowitz D: Differential control of central cardiorespiratory interactions by hypercapnia and the effect of prenatal nicotine. J Neurosci 2006;26:21-29.
28.
Janson C: The effect of passive smoking on respiratory health in children and adults. Int J Tuberc Lung Dis 2004;8:510-516.
29.
Scholl TO, Johnson WG: Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr 2000;71(5 suppl):1295S-1303S.
30.
Dean JC, Hailey H, Moore SJ, Lloyd DJ, Turnpenny PD, Little J: Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 2002;39:251-259.
31.
Kang S, Shi Y, Li Y, Wang N, Lu Y, Zhou R, Zhao X: Association between genetic variants of the VEGFR-2 gene and the risk of developing endometriosis in Northern Chinese women. Gynecol Obstet Invest 2013;76:32-37.
32.
Song C, Xie S, Wang J, Lian J, Diao B, Tang Y: Association of angiotensinogen gene polymorphisms and angiogenic factors with preeclampsia in Chinese women. Gynecol Obstet Invest 2013;76:64-68.
33.
Romero R, Velez Edwards DR, Kusanovic JP, Hassan SS, Mazaki-Tovi S, Vaisbuch E, Kim CJ, Chaiworapongsa T, Pearce BD, Friel LA, Bartlett J, Anant MK, Salisbury BA, Vovis GF, Lee MS, Gomez R, Behnke E, Oyarzun E, Tromp G, Williams SM, Menon R: Identification of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes. Am J Obstet Gynecol 2010;202:431.e1-e34.
34.
Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, Bailey-Wilson JE, Silverberg MS, Duerr RH, Cho JH, Gregersen PK, Wu Y, Achkar JP, Dassopoulos T, Mezey E, Bayless TM, Nouvet FJ, Brant SR: Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Gene 2004;13:35-45.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.